Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07225751 · ClinicalTrials.gov registry record · NA

A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

A NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty, sponsored by Kuros Biosurgery.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
4
Study locations

NCT07225751 is a NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty that is actively recruiting participants, run by Kuros Biosurgery. The registered enrollment target is 126 participants. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07225751, a NA study of Hindfoot Arthrodesis and Ankle Arthrodesis or Arthroplasty, is actively recruiting participants, sponsored by Kuros Biosurgery.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
4
Study locations

Study Summary

This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use according to the latest Instructions For Use, standalone in the foot and ankle.

Interventions

  • DEVICE MagnetOs
  • OTHER Autograft

Study Locations (4)

Colorado

  • Steadman Philippon Research Institute - Vail

Georgia

  • Hughston Foundation Inc - Columbus

Pennsylvania

  • Reconstructive Orthopaedic Associates II dba Rothman Orthopaedic Institute - Philadelphia

Tennessee

  • Erlanger Orthopaedics - Chattanooga

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2025-11-25
Est. Completion 2028-12
Phase NA

Sponsor

Kuros Biosurgery

4 total trials

What the Registry Record Tells You About NCT07225751

The ClinicalTrials.gov registry entry for NCT07225751 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kuros Biosurgery, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hindfoot Arthrodesis appearing as the primary indexed condition, and to 2 interventions - of which MagnetOs is the first listed.

NCT07225751 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Georgia, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07225751 about?

NCT07225751 is a clinical study titled "A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.". This is a phase IV post-marketing study for MagnetOs Putty and MagnetOs Easypack Putty. MagnetOs is a synthetic bone graft extender product that is routinely used by surgeon as treatment for hindfoot and ankle disorders. In this study, MagnetOs Putty and MagnetOs Easypack Putty will be use accordin...

What is the current status of trial NCT07225751?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2025-11-25. Estimated completion is 2028-12.

What conditions does trial NCT07225751 study?

This clinical trial studies the following conditions: Hindfoot Arthrodesis, Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease.

What interventions are being tested in trial NCT07225751?

The interventions under investigation include: MagnetOs (DEVICE), Autograft (OTHER).

Who is sponsoring clinical trial NCT07225751?

This trial is sponsored by Kuros Biosurgery, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07225751 being conducted?

This trial has 4 study locations across Colorado, Georgia, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hindfoot Arthrodesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.